Tratamiento y resultado clínico de un paciente con rabdomiosarcoma de células huso que alberga la fusión del gen MEIS1-FOXO1
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.El rabdomiosarcoma de células del husillo (SRMS) es raro, pero se identificó una nueva fusión del gen MEIS1-FOXO1. El manejo exitoso involucró cirugía, radiación y quimioterapia, ofreciendo un paradigma de tratamiento potencial.
Área De La Ciencia
- En el campo de la oncología
- Diagnóstico molecular
- La genética
Sus Antecedentes
- El rabdomiosarcoma extraosseoso impulsado por fusión (SRMS) es un subtipo raro con datos limitados de tratamiento.
- La comprensión de la base molecular del SRMS es crucial para el desarrollo de terapias dirigidas.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...